Eli Lilly (LLY) PT Raised to $358 at BMO Capital
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,185.05 -1.84%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BMO Capital analyst Evan David Seigerman raised the price target on Eli Lilly (NYSE: LLY) to $358.00 (from $330.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Lilly files six lawsuits over illegal sales of unapproved retatrutide
- Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
